Prepare for Questions About Xolair for Food Allergies
May 2024
Omalizumab (Xolair) is the first monoclonal antibody FDA-approved for patients with food allergies.
It joins the approved oral immunotherapy Palforzia...a peanut allergen powder for desensitization in patients with peanut allergy.
But omalizumab blocks IgE...to reduce allergic reactions from accidental exposure to one or more foods, such as peanuts, eggs, or milk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote